US Broker Ratings

CG Oncology, Inc. (CGON) Stock Analysis: A Biotech Contender with a 124% Upside Potential

Investors with an eye on the biotechnology sector might find CG Oncology, Inc. (NASDAQ: CGON) an intriguing candidate, primarily due to its substantial growth potential. With a market cap of..

Azenta, Inc. (AZTA) Stock Analysis: Navigating a 2.97% Upside in the Medical Instruments Sector

For investors eyeing opportunities in the healthcare sector, Azenta, Inc. (NASDAQ: AZTA) presents a compelling case, especially given its strategic positioning in the medical instruments and supplies industry. With a..

Immunocore Holdings plc (IMCR) Stock Analysis: 68% Potential Upside Draws Investor Attention

Immunocore Holdings plc (NASDAQ: IMCR), a trailblazer in the biotechnology sector, commands investor interest with a compelling potential upside of 68.37%. Specializing in immunotherapies for cancer, infectious, and autoimmune diseases,..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A Biotech with 189.90% Potential Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising player in the biotechnology industry, is capturing investor attention with its robust pipeline and a staggering potential upside of 189.90%. Headquartered in Boulder,..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 65% Potential Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) has been making waves in the healthcare sector, specifically within the niche of medical instruments and supplies. Based in Kirkland, Washington, Kestra is focused..

CONMED Corporation (CNMD) Stock Analysis: Eyeing a 39% Potential Upside in the Medical Device Market

For investors with an interest in the healthcare sector, particularly medical devices, CONMED Corporation (NASDAQ: CNMD) presents a compelling proposition. The company, with a market capitalization of $1.48 billion, has..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: A 15% Upside Potential in the Biotech Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a key player in the biotechnology sector, is attracting investor attention with its promising growth potential and strategic collaborations. Headquartered in Seattle, Washington, this commercial-stage..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Promising Biotech Pioneer with 63% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) has carved out a significant niche in the biotechnology sector by focusing on rare diseases, a strategy that has captured investor interest due to its..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Unveiling a 340% Potential Upside for Bold Investors

Dyne Therapeutics, Inc. (NASDAQ: DYN) is emerging as a captivating opportunity within the biotechnology sector, boasting a remarkable 340% potential upside that has piqued the interest of investors. This clinical-stage..

NewAmsterdam Pharma (NAMS) Stock Analysis: Strong Buy Ratings and an 86% Upside Potential

NewAmsterdam Pharma Company N.V. (NAMS), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising pipeline and substantial upside potential. Headquartered in Naarden, the Netherlands, NewAmsterdam..

Novavax, Inc. (NVAX): Investor Outlook on a Biotech Firm with 87% Upside Potential

Novavax, Inc. (NASDAQ: NVAX) is a notable player in the biotech sector, particularly as it continues its pioneering efforts in vaccine development. With a focus on combatting serious infectious diseases,..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 292.54% Upside Potential in the Biotechnology Sector

Biohaven Ltd. (BHVN) stands as a notable player in the biotechnology industry, with a market capitalization of $1.41 billion. Headquartered in New Haven, Connecticut, Biohaven is dedicated to discovering, developing,..

Arcutis Biotherapeutics (ARQT) Stock Analysis: A Deep Dive into Its 47.44% Potential Upside

In the vibrant arena of biotechnology, Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is attracting significant attention with its promising portfolio of dermatological treatments, coupled with a compelling 47.44% potential upside according..

Organon & Co. (OGN) Stock Analysis: Evaluating the 48% Potential Upside Amidst Current Challenges

Organon & Co. (NYSE: OGN) presents an intriguing opportunity for investors within the healthcare sector, particularly in the general drug manufacturing industry. With a significant market presence spanning several continents,..

Dynavax Technologies (DVAX) Investor Outlook: Navigating a Promising 112.75% Upside Potential

Dynavax Technologies Corporation (NASDAQ: DVAX), a leading player in the healthcare sector, continues to captivate investor interest with its strong potential for future growth. With a market capitalization of $1.31..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 39.25% Potential Upside in Health Information Services

Schrodinger, Inc. (NASDAQ: SDGR) is capturing the attention of investors with a robust potential upside of 39.25%, according to current analyst ratings. Positioned squarely in the healthcare sector, specifically within..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating a 17.36% Potential Upside in the CNS Market

Supernus Pharmaceuticals, Inc. (SUPN), a prominent player in the healthcare sector, operates within the niche of drug manufacturers specializing in both specialty and generic products. Based in Rockville, Maryland, Supernus..

Addus HomeCare Corporation (ADUS) Stock Analysis: 27% Upside Potential Amid Robust Revenue Growth

Addus HomeCare Corporation (NASDAQ: ADUS), a key player in the healthcare sector, stands out with its promising financial metrics and growth prospects. With a market capitalization of $1.98 billion, this..

Ligand Pharmaceuticals (LGND): Investor Outlook on a Biotech Leader with a 46% Revenue Growth Surge

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a key player in the biotechnology sector, stands out with its robust portfolio of biopharmaceutical assets. The company, headquartered in Jupiter, Florida, has carved a..

Amedisys Inc (AMED) Stock Analysis: Navigating Valuation Metrics and Growth Potential in the Healthcare Sector

Amedisys Inc. (NASDAQ: AMED), a prominent player in the healthcare sector, operates in the medical care facilities industry, specializing in providing crucial home health, hospice, and high acuity care services..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds